Vicks Formula 44

Sneezing, Tracheitis, Emphysema + 43 more

Treatment

5 FDA approvals

20 Active Studies for Vicks Formula 44

What is Vicks Formula 44

Guaifenesin

The Generic name of this drug

Treatment Summary

Dextromethorphan is a medication used to reduce coughing. It is a derivative of levorphanol and a codeine analog that does not interact with opioid receptors. It was approved by the FDA before December 1957. It is also sometimes used recreationally, and can be abused.

Goyescas 7 Syrups Original Cough and Cold

is the brand name

image of different drug pills on a surface

Vicks Formula 44 Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Goyescas 7 Syrups Original Cough and Cold

Guaifenesin

1958

497

Approved as Treatment by the FDA

Guaifenesin, also called Goyescas 7 Syrups Original Cough and Cold, is approved by the FDA for 5 uses which include Productive cough and induction of Productive cough .

Productive cough

induction of Productive cough

chest congestion

Phlegm

Coughing

Effectiveness

How Vicks Formula 44 Affects Patients

Dextromethorphan is a medication used to treat coughs and pseudobulbar affect, usually combined with other drugs. Taking too much of this drug can cause intoxication, so caution should be taken when using it. It works for a moderate amount of time.

How Vicks Formula 44 works in the body

Dextromethorphan works by activating certain receptors in the body. It is unclear exactly how this activation leads to its clinical effects.

When to interrupt dosage

The recommended amount of Vicks Formula 44 is contingent upon the diagnosed affliction, for instance Coughing, Fever and Antisepsis. The dosage also depends on the technique of delivery featured in the table beneath.

Condition

Dosage

Administration

Phlegm

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Common Cold

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Whooping Cough

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

House dust allergy

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Hives

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Acute Bronchitis

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Exanthema

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Bronchial Spasm

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Rhinitis, Allergic

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Productive cough

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Coughing

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Rhinorrhea

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Fever

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Influenza

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Chronic Obstructive Pulmonary Disease

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Tobacco Use

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Pharyngitis

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Bronchitis, Chronic

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Food Hypersensitivity

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Asthma

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Warnings

Vicks Formula 44 has one contraindication. It should not be paired with the conditions listed in the following table.

Vicks Formula 44 Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Guaifenesin may interact with Pulse Frequency

Common Vicks Formula 44 Drug Interactions

Drug Name

Risk Level

Description

Vicks Formula 44 Toxicity & Overdose Risk

Overdosing on dextromethorphan can cause nausea, vomiting, confusion, difficulty breathing, seizures, fast heart rate, agitation, hallucinations, impaired coordination, blurred vision, reflex changes, and serotonin syndrome. Treatment for overdose should focus on relieving symptoms and supporting the patient.

Vicks Formula 44 Novel Uses: Which Conditions Have a Clinical Trial Featuring Vicks Formula 44?

134 active clinical trials are currently assessing the potential of Vicks Formula 44 in alleviating Influenza, Pseudobulbar Affect (PBA) and Coughing.

Condition

Clinical Trials

Trial Phases

Tracheitis

0 Actively Recruiting

Fever

2 Actively Recruiting

Not Applicable, Phase 4

Asthma

92 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3

Chronic Obstructive Pulmonary Disease

76 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Coughing

0 Actively Recruiting

chills occurring with fever

0 Actively Recruiting

Influenza

29 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3

Tobacco Use

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Pain

0 Actively Recruiting

Coughing

0 Actively Recruiting

excess mucus or phlegm

0 Actively Recruiting

Coughing

0 Actively Recruiting

Laryngitis

0 Actively Recruiting

Whooping Cough

0 Actively Recruiting

Exanthema

0 Actively Recruiting

Coughing

0 Actively Recruiting

Emphysema

4 Actively Recruiting

Phase 2, Not Applicable

Acute Bronchitis

1 Actively Recruiting

Not Applicable

Vicks Formula 44 Reviews: What are patients saying about Vicks Formula 44?

5

Patient Review

3/27/2021

Vicks Formula 44 for Cough

Vicks Formula 44 has been a trusted cough medicine in my family for generations. It's always worked quickly and efficiently to relieve late-season allergies coughing fits.

5

Patient Review

1/30/2016

Vicks Formula 44 for Cough

I had some early in the morning and started feeling incredibly dizzy. I'm allergic to Codeine, and the symptoms were very similar. Not sure if it's the medicine or the sugar, but either way it was a pretty scary experience.

4

Patient Review

3/11/2014

Vicks Formula 44 for Cough

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about vicks formula 44

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

When was Vicks Formula 44 discontinued?

"P&GHHCL may look at relaunching its cough syrup "Vicks Formula 44," subject to a change in government regulations in future."

Answered by AI

Does Vicks Formula 44 DM have alcohol in it?

"The text is saying that NyQuil Cold & Flu is alcohol free. It lists the active ingredients as acetaminophen, chlorpheniramine maleate, and dextromethorphan HBr."

Answered by AI

What does Vicks Formula 44 do?

"This product also contains an antihistamine (such as diphenhydramine, doxylamine) that may also be used to help you feel less nauseated, to help you fall asleep, and to relieve other symptoms of the common cold or allergies.

Generic Name: doxylamine-dextromethorphan This combination product is used for the temporary relief of cough, sneezing, or runny nose due to the common cold, hay fever or other upper respiratory allergies. This product contains a non-opioid cough suppressant (chlophedianol, dextromethorphan). This product also contains an antihistamine (diphenhydramine, doxylamine) that may also be used to help you feel less nauseated, to help you fall asleep, and to relieve other symptoms of the common cold or allergies."

Answered by AI

Is Vicks Formula 44 still available?

"Dextromethorphan HBr is no longer available for purchase."

Answered by AI

Clinical Trials for Vicks Formula 44

Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Have you considered Vicks Formula 44 clinical trials?

We made a collection of clinical trials featuring Vicks Formula 44, we think they might fit your search criteria.
Go to Trials
Image of Stanford University in Stanford, United States.

MoblO2 for Chronic Lung Diseases

18+
All Sexes
Stanford, CA

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course. Practitioners prescribe O2 to patients with chronic lung disease in hopes of the following: 1) that it will limit desaturation events and combat breathlessness, thus preventing the frustratingly slow pace and numerous rest breaks patients are forced to adopt while doing even simple tasks; 2) that it will allow patients to be more active physically (perhaps increase their ability to exercise) and socially (perhaps leave the home more often); 3) that it will stave off putative complications of hypoxemia (e.g., cognitive dysfunction, pulmonary hypertension) and 4) that it will improve health-related quality of life (HRQL). However, despite the rationale for O2, and prescribers' good intentions, patients generally view O2 with frustration and fear - it threatens their HRQL, which is already impaired by having a condition that imposes itself on every aspect of their lives. Nasal cannulas and delivery devices call unwanted attention to patients when they are out in public. O2 users feel stigmatized and are often viewed as "smokers who get what they deserve, even if they never smoked a day in their lives" - or as disabled, sick or even infectious. O2 steals patients' independence, forcing them to plan their lives around it. The anxiety that patients and their caregivers experience around running out of oxygen, or not getting enough, immobilizes them and restricts participation in activities outside of the home. O2 disrupts the home environment, adding stress, and creating a burden for patients' caregiver-loved-ones who are often saddled with the responsibility of ensuring adequate equipment and supply of O2, and O2 is a constant reminder to patients they are living with a condition that could shorten their lives. O2 delivery equipment is typically heavy, unwieldy and intimidating. Different recommendations (e.g., insurance companies use 88% as a cut-off for SpO2, while many practitioners focus on 90%) make it confusing for patients, which almost certainly affects adherence. O2-requiringpatients are starving for things that can make their lives easier. An auto-adjusting O2 delivery device - one that automatically delivers the correct amount of O2 to maintain blood oxygen at desired, pre-set levels - would alleviate the need for patients to constantly (incessantly for many) monitor their peripheral oxygen saturation (SpO2) and adjust O2flow to meet the demands as exertion levels vary . The MoblO2 device is a battery-operated, light-weight, closed-loop O2 delivery device that houses a regulator (which attaches to compressed gas O2 tanks) and adjusts O2 flow to meet a pre-set blood oxygen level. A pulse oximeter is worn on the ear and transmits via Bluetooth to the device, which adjusts an internal valve to control flow on a second-to-second basis. The user sets the dial to the highest flow of O2 needed to meet the demands of activities they might perform (up to 15 liters per minute), and the device adjusts flow, up to the pre-set level to maintain SpO2 at a preset level (e.g., \> 90%). To conserve O2 supply in the tank - and to avoid over-oxygenation (which could be problematic for a small percentage of patients with the most severe COPD) - the MoblO2 begins to limit O2 flow at a SpO2 of 93%. The device can be manually over-ridden by the user, and should the battery run out - or the device fail for some unforeseen reason - the default position is valve open, so the users receive whatever flow of oxygen has been set on the dial. Given the substantial burdens of O2 on patients and their families, the hassles patients describe with having to monitor their SpO2 and repeatedly adjust the flow of O2 to meet their needs, patients and experts around the world have called for improvements in O2 delivery equipment. The MoblO2 is just such a remarkable improvement and a giant step forward in helping to ease the burdens of O2 on patients who require it. The purpose of this study is to investigate the effects of the MoblO2 O2 delivery device on a range of outcomes, including physical activity, amount (liters) O2 use; maintenance of adequate SpO2 levels; patient reported outcomes including symptoms, HRQL and satisfaction with the MoblO2 O2 device.

Waitlist Available
Has No Placebo

Stanford University

Jeff Swigris, DO, MS

Minnesota Health Solutions

Have you considered Vicks Formula 44 clinical trials?

We made a collection of clinical trials featuring Vicks Formula 44, we think they might fit your search criteria.
Go to Trials
Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.

Phase 2
Waitlist Available

National Institutes of Health Clinical Center (+1 Sites)

Luca T Giurgea, M.D.

Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN

This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?

Phase 2
Recruiting

Vanderbilt University Medical Center

Natahsa Halasa, MD, MPH

Have you considered Vicks Formula 44 clinical trials?

We made a collection of clinical trials featuring Vicks Formula 44, we think they might fit your search criteria.
Go to Trials